FIG. 2.

Sequence alignments for the BDV p40 amplification products obtained from the RNA-transcribed plasmid p40 INS containing a 56-bp insertion (line 1), an HIV-infected patient with a BDV containing a 120-bp deletion (line 2), an immunocompromised HIV-negative patient (line 3), and BDV-infected C6 cells (line 4).